Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-enhanced Chemotherapy in Liver Metastasis
NCT03477019Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Nov 2018
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (4 arms), sponsored by St. Olavs University Hospital. Primary endpoint: Difference in measured response between treated and untreated lesions. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT03477019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477019.